These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31633881)

  • 1. Cell transfer-based immunotherapies in cancer: A review.
    Gorabi AM; Hajighasemi S; Sathyapalan T; Sahebkar A
    IUBMB Life; 2020 Apr; 72(4):790-800. PubMed ID: 31633881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive immunotherapy of cancer using activated autologous lymphocytes--current status and new strategies.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Shimizu K; Minami K; Hihara J; Miyahara E; Toge T
    Hum Cell; 2003 Dec; 16(4):183-9. PubMed ID: 15147038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell therapy in solid tumors].
    Ravaud A
    Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
    [No Abstract]   [Full Text] [Related]  

  • 4. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-associated cellular immunotherapy for lung cancer.
    Li K; Zhang Q; Zhang Y; Yang J; Zheng J
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1249-58. PubMed ID: 25381064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cells Therapy with Cytokine-Induced Killer Cells and Activated Cytotoxic T Cells Attenuated Th2 Bias Immune Response.
    Li C; Zhu D; Zhao Y; Guo Q; Sun W; Li L; Gao D; Zhao P
    Immunol Invest; 2020 Jul; 49(5):522-534. PubMed ID: 31793363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?
    Thanendrarajan S; Nowak M; Abken H; Schmidt-Wolf IG
    Leuk Res; 2011 Sep; 35(9):1136-42. PubMed ID: 21652069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular immunotherapy of cancer].
    Kawakami Y
    Rinsho Ketsueki; 2003 Jun; 44(6):358-67. PubMed ID: 12884813
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.
    Kim S; Haas GP; Hillman GG
    Cytokines Mol Ther; 1996 Mar; 2(1):13-9. PubMed ID: 9384685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell transfer therapy for cancer: past, present, and future.
    Qian X; Wang X; Jin H
    J Immunol Res; 2014; 2014():525913. PubMed ID: 24741604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding a place for tumor-specific T cells in targeted cancer therapy.
    Riddell SR
    J Exp Med; 2004 Dec; 200(12):1533-7. PubMed ID: 15611285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunotherapy with recombinant interleukin 2, LAK and TIL.
    Kurnick JT; Kradin RL
    Allergol Immunopathol (Madr); 1991; 19(5):209-14. PubMed ID: 1811418
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell therapy: achievements and perspectives.
    Bordignon C; Carlo-Stella C; Colombo MP; De Vincentiis A; Lanata L; Lemoli RM; Locatelli F; Olivieri A; Rondelli D; Zanon P; Tura S
    Haematologica; 1999 Dec; 84(12):1110-49. PubMed ID: 10586214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of interleukin-2 therapy in cancer.
    Tartour E; Mathiot C; Fridman WH
    Biomed Pharmacother; 1992; 46(10):473-84. PubMed ID: 1306361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transfer.
    Paul S; Calmels B; Acres RB
    Curr Gene Ther; 2002 Feb; 2(1):91-100. PubMed ID: 12108977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumours by adoptive transfer of immune cells.
    Macary PA; Too CT; Dai X
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):569-74. PubMed ID: 16700896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunotherapy of cancer: an overview and future directions.
    Tao Z; Li S; Ichim TE; Yang J; Riordan N; Yenugonda V; Babic I; Kesari S
    Immunotherapy; 2017 Jun; 9(7):589-606. PubMed ID: 28595516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive cell therapy: Honing that killer instinct.
    Humphries C
    Nature; 2013 Dec; 504(7480):S13-5. PubMed ID: 24352359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.